Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial

The Lancet ◽  
2017 ◽  
Vol 389 (10070) ◽  
pp. 709-717 ◽  
Author(s):  
Meike H van der Ree ◽  
J Marleen de Vree ◽  
Femke Stelma ◽  
Sophie Willemse ◽  
Marc van der Valk ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Randomised Controlled Trial ◽  
Chronic Hepatitis C ◽  
Controlled Trial ◽  
Antiviral Effect ◽  
Double Blind ◽  
Phase 1B ◽  
Randomised Controlled

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

2001 ◽  
Vol 120 (5) ◽  
pp. A384-A384
Author(s):  
L MOLLISON ◽  
L TOTTEN ◽  
C HOVELL ◽  
K THAYNE ◽  
C CONNELLY ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Controlled Trial ◽  
Herbal Preparation ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Chinese Herbal
Sign in / Sign up

Export Citation Format

Share Document